Drug recall · March 12, 2014
Alprazolam Extended-Release Tablets recall
Why: Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle, Rx only, Manufactured by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-3086-06, UPC 3 0228-3086-06 2.
- Lots / codes
Lot #: 57617531, Exp 03/14
- Quantity
- 5,148 bottles
- Company
- Actavis Elizabeth LLC, Elizabeth, NJ
- Distribution
- Nationwide
- Initiated
- February 4, 2014 · Voluntary: Firm initiated
- Classified
- February 28, 2014
- Reported
- March 12, 2014
- Ended
- January 22, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.